Ocular Therapeutix Statistics
NASDAQ: OCULHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.23-0.11 (-1.50%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Ocular Therapeutix by the numbers
Ocular Therapeutix has a market capitalization of $1.59 billion based on 219.62M shares outstanding. With trailing EPS of $-1.38, Ocular Therapeutix is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 25.5% below its 50-day average and 24.4% below its 200-day average.
Average daily trading volume is 2.78M shares, or about $20.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
OCUL valuation vs. peer median
| Metric | OCUL | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.59B | $1.68B | -5% |
| Avg. volume | 2.78M | 1.50M | +85% |
Peer median across 8 companies: CMPS, QURE, ANIP, BRVE, SEPN, NUVB, GENB, BHVN.
Valuation
- Market cap
- $1.59B
- EPS (TTM)
- $-1.38
- Shares outstanding
- 219.62M
Price and trading
- Previous close
- 7.34
- Open
- 7.26
- Day range
- 7.19 – 7.55
- 52-week range
- 6.23 – 16.44
- 52-week change
- -37.24%
- Beta
- —
- Volume
- 2.92M
- Average volume
- 2.78M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 1.59B
- Forward Pe
- -4.97
- Eps
- -1.38
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 16.44
- Week52 Low
- 6.23
- Avg Volume
- 2.78M
- Shares Outstanding
- 219.62M
- Ma50
- 9.71
- Ma200
- 9.56
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -56.02%
- Pct From52w Low
- 16.05%